The biology of Hepatocellular carcinoma: implications for genomic and immune therapies

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is a leading cause of cancer-related death worldwide. It is highly refractory to most systemic therapies. Recently, significant progress has been made in uncovering genomic alterations in HCC, including potentially targeta...

Descripción completa

Detalles Bibliográficos
Autores principales: Khemlina, Galina, Ikeda, Sadakatsu, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577674/
https://www.ncbi.nlm.nih.gov/pubmed/28854942
http://dx.doi.org/10.1186/s12943-017-0712-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577674/
https://www.ncbi.nlm.nih.gov/pubmed/28854942
http://dx.doi.org/10.1186/s12943-017-0712-x

Ejemplares similares